| ELISA kit stock availability: |
Available In Stock |
| ELISA's description: |
Human Liver-expressed antimicrobial peptide 2 (LEAP2) Control/blocking peptide |
| Category: |
Antibody Blocking Peptide |
| S type: |
Synthetic peptide (inquire immunogen) |
| Antibody's host is: |
see techfile |
| Purification: |
Affinity purified |
| Properties: |
Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Human proteins, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine, , (Homo sapiens, Homo sapiens sapiens), blocking peptide, humans , ssp |
| Description: |
, The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs, The shortest peptides are dipeptides, These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), and unbranched synthetic peptide chains, consisting of 2 amino acids joined by a single peptide bond, continuous, followed by tripeptides, or in continue produced for custom peptide synthesis projects, tetra peptides, till polypeptides that are long, Peptides short amino acid chains or epitopes or blocking antagonists |
| Gene target: |
Liver-expressed antimicrobial peptide 2 (LEAP2) / |
| Short name: |
Liver-expressed antimicrobial peptide 2 (LEAP2) Control/blocking peptide |
| Technique: |
For western blot it is often requested to block your antibody and to see the band of the analyzed protein disappear, This is called a negative control by blocking the WB antibody, adi made this blocking amino acid sequence or peptide to block the gene target in a volume of 1, controls, peptides, blocking peptide |
| Species: |
Humans, Human |
| Alternative name: |
sapiens Liver-expressed antimicrobial short protein sequence 2 (liver expressed antimicrobial peptide 2) reference/inhibiting short protein sequence, H |
| Alternative technique: |
controls |
| Alternative to gene target: |
Extracellular, LEAP2 and IDBG-43708 and ENSG00000164406 and 116842, LEAP2 and IDBG-645718 and ENSBTAG00000018926 and 282270, Leap2 and IDBG-171608 and ENSMUSG00000036216 and 259301, this GO :0005576 and extracellular region and cellular component this GO :0042742 and defense response to bacterium and biological process, liver expressed antimicrobial peptide 2 |
| Identity: |
29571 |
| Gene: |
LEAP2 |
More about : LEAP2 |
| Long gene name: |
liver enriched antimicrobial peptide 2 |
| Synonyms gene name: |
liver expressed antimicrobial peptide 2 |
| Synonyms: |
LEAP-2 |
| Locus: |
5q31, 1 |
| Discovery year: |
2006-08-22 |
| GenBank acession: |
AJ409065 BX443829 |
| Entrez gene record: |
116842 |
| Pubmed identfication: |
12493837 |
| RefSeq identity: |
NM_052971 |
| Havana BLAST/BLAT: |
OTTHUMG00000059837 |